The evidence on peptides — delivered weekly. Subscribe free →

Oxytocin

low risk

Also: Syntocinon · Pitocin · Love hormone

Strong Evidence FDA Approved

Oxytocin is an FDA-approved nonapeptide hormone with well-characterized roles in parturition and social bonding. Intranasal oxytocin is extensively researched for social anxiety, autism spectrum disorder, and PTSD — with mixed Phase II results. The 'love hormone' narrative has outpaced the evidence in some areas.

Molecular Weight
1007.2 Da
Formula
C43H66N12O12S2
Common Dosing
IV: 10–40 units for labor induction (approved). Intranasal: 24–40 IU for research/off-label social/anxiety applications
Category
therapeutic
Last Reviewed
2025-01-15

Reported Benefits

Labor induction / postpartum hemorrhage

Strong Evidence 200 studies

FDA-approved standard of care. Well-established obstetric pharmacology.

Social anxiety / autism

Moderate Evidence 45 studies

Multiple Phase II trials; modest and variable effects on social cognition in ASD. Results inconsistent across trials.

PTSD / fear extinction

Preliminary 22 studies

Preclinical and early human data suggest facilitation of fear extinction; inconsistent clinical results.

Mechanism of Action

Binds oxytocin receptor (OXTR); activates phospholipase C and IP3 signaling; increases intracellular calcium; uterotonic effects in parturition; modulates social behavior, trust, and bonding via limbic system.

Key Clinical Studies

Flanagan et al. (2021)

Phase II RCT · n=290

PubMed →

Intranasal oxytocin did not significantly improve social outcomes vs. placebo in young ASD children

The Hype Gap

Oxytocin’s popular reputation as the ‘love hormone’ has generated enormous expectations that clinical trials have not consistently fulfilled, particularly in autism. The IV obstetric application is rock-solid evidence. The intranasal behavioral applications show modest, variable effects in the best trials and null results in others.

This is a useful case study in translational difficulty — from compelling animal social behavior data to inconsistent human clinical results.

Regulatory Status

FDA Approved

FDA approved (Pitocin, Syntocinon) for obstetric use

Safety Profile

Side Effects

  • •Uterotonic effects (dangerous outside obstetric settings)
  • •Water intoxication (IV)
  • •Nasal congestion (intranasal)
  • •Hypotension

Contraindications

  • •Fetal distress
  • •Mechanical obstruction to delivery
  • •Unfavorable fetal position (IV use)

Drug Interactions

  • •Ergot alkaloids (synergistic uterotonic risk)

Primary Uses

Labor inductionPostpartum hemorrhageSocial bondingAutism (research)Anxiety

Related Peptides

selanksemaxkisspeptin-10

Weekly Briefing

Regulatory updates + new study breakdowns.

For Practitioners

Do you prescribe Oxytocin?

Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.

Get Listed →
Disclaimer: This information is for educational and research purposes only. Not medical advice. Consult a qualified healthcare provider before using any compound.